Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-17

Clinical Trial Update: Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia [NA]

View source ↗

Summary

A terminated clinical trial evaluated oral progesterone plus low-dose aspirin for the prevention of preeclampsia, and the results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • PROGESTERONE (Progesterone)

Snippet

Sponsor: John Uckele | Conditions: Preeclampsia | NA | Status: TERMINATED | Results posted: 2017-04-17